Startup Spotlight

Unaffordable, imprecise, and an untimely disease diagnosis undermines the global healthcare system, contributing to increased morbidity and mortality. The rising prevalence of diseases such as cancer and neurological disorders need a timely diagnosis for better management. New drug therapies for chronic diseases are needed and being developed, but currently, the cost of development through screening and trials of compounds is prohibitive, restricting patient access. Through their novel technology, ChronosDx is developing a promising bioassay to circumvent these challenges.

George William Ssendagala

December 13, 2024

Currently based at the University of Sheffield in the Chemical and Biological Engineering department, Evolutor was created following the amazing work of Prof. Tuck Seng Wong and Dr Kang Lan Tee, through which CEO, Joe Price, envisioned the evolutionary microbe development company: Evolutor. Evolutor’s Accelerated Evolution Platform allows them to use the power of adaptive evolution to create improved microbes for industrial usage. With this platform, their ambition is to build the world’s first evolutionary bio-foundry...

Rachel Thompson

December 13, 2024

Pear Bio is revolutionising the way cancer treatments are assigned to patients. They have developed a functional precision medicine platform by integrating tissue engineering, confocal microscopy, and computer vision into a single patient stratification tool. This facilitates the assessment of the treatment efficacy in the human tumour microenvironment by modelling the impact a drug or a combination of drugs has on the progression of disease.

Aonghus Topham

December 13, 2024

The biomanufacturing industry is currently experiencing a ground-breaking transformation driven by the integration of AI and new technologies that make high-throughput engineering possible. This paradigm shift has not only pushed the boundaries of biological capabilities, but has also prompted several companies to challenge traditional biomanufacturing methods. Among them, Eden Bio stands out with its bold ambition to redesign and optimise the process for unprecedented efficiency.

December 13, 2024

Synthetic biology has grown tremendously popular in recent years, following successes from the realms of gene therapies to sustainable agriculture and much more. Our next guest on the SEC series truly embodies the ‘dogma breaking’ aspect of synthetic biology, targeting the inside of our cells through their start-up NanoSyrinx.

Charles Leach

December 13, 2024

The first period tracking app was released in 2013, and approximately 100 million people use a period tracking app today. With this growth, over 10 years, period tracking apps seem like an exponential success. Yet, every month, around 1.8 billion people in the global population menstruate, suggesting there is a side of the market that is currently being unfulfilled.

Natasha Barrow

December 13, 2024